Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ISRG Stock Summary
In the News
Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
Intuitive Surgical, Inc. (ISRG) reachead $400.24 at the closing of the latest trading day, reflecting a +0.66% change compared to its last close.
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
1 New Reason to Buy Intuitive Surgical Stock and Hold Forever
Intuitive Surgical is now approved to launch its latest surgical robot. The latest da Vinci surgical unit has key features that no competitor has.
1 Magnificent Growth Stock to Buy and Hold
Intuitive Surgical has made a name for itself with its robotic-assisted surgical systems. Though it faces some near-term headwinds, the company's prospects look exciting.
Springtime Profits: 3 Growth Stocks Poised to Bloom in March
When seeking out potential investments, focusing on growth stocks can be a lucrative strategy for investors. Innovative companies with solid growth prospects often outperform the market, as represented by the S&P 500 index.
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
Intuitive Surgical, Inc. (ISRG) closed at $390.53 in the latest trading session, marking a -0.53% move from the prior day.
Hot Stocks: The 3 Best Opportunities for Investing in Robotics
If you're paying attention, there's a robotics stocks revolution quietly underway. While headlines holler about imminent worker replacement by hordes of AI-enabled robots, the truth is much more optimistic.
Intuitive Surgical: Great Company, But Looking Overpriced
Intuitive Surgical is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. I saw a 21% increase in sales for their flagship da Vinci procedures robot, which the company expects to continue. Revenue increased 17% to $1.9bn vs 2022 Q4, with a solid and stable gross margin of 66%.
7 Stocks That Are Making Other CEOs Lose Sleep at Night
There are seven stocks making CEOs lose sleep in March this year, reflecting the immense pressures and challenges facing major corporations across various industries. Some companies are reeling from product safety crises that have shaken consumer confidence while exposing them to staggering litigation risks.
ISRG Financial details
ISRG Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.94 | 12.42 | 16.04 | 17.49 | 20.29 | |
Net income per share | 3.98 | 3.02 | 4.79 | 3.72 | 5.12 | |
Operating cash flow per share | 4.62 | 4.23 | 5.87 | 4.19 | 5.16 | |
Free cash flow per share | 3.39 | 3.26 | 4.87 | 2.69 | 2.13 | |
Cash per share | 9.31 | 14.73 | 11.88 | 11.59 | 14.87 | |
Book value per share | 23.93 | 27.8 | 33.56 | 31.24 | 37.89 | |
Tangible book value per share | 22.72 | 26.62 | 32.4 | 30.12 | 35.34 | |
Share holders equity per share | 23.93 | 27.8 | 33.56 | 31.24 | 37.89 | |
Interest debt per share | -1.64 | 0.06 | 0.3 | 0.15 | -0.16 | |
Market cap | 68.22B | 95.72B | 127.95B | 94.38B | 118.48B | |
Enterprise value | 67.13B | 94.18B | 126.74B | 92.9B | 115.82B | |
P/E ratio | 49.46 | 90.25 | 75.06 | 71.38 | 65.9 | |
Price to sales ratio | 15.23 | 21.96 | 22.41 | 15.17 | 16.63 | |
POCF ratio | 42.68 | 64.47 | 61.24 | 63.31 | 65.32 | |
PFCF ratio | 58.18 | 83.72 | 73.71 | 98.48 | 158.06 | |
P/B Ratio | 8.23 | 9.81 | 10.71 | 8.49 | 8.9 | |
PTB ratio | 8.23 | 9.81 | 10.71 | 8.49 | 8.9 | |
EV to sales | 14.99 | 21.61 | 22.2 | 14.93 | 16.26 | |
Enterprise value over EBITDA | 48.84 | 89.71 | 69.6 | 58.9 | 52.92 | |
EV to operating cash flow | 42 | 63.43 | 60.66 | 62.31 | 63.86 | |
EV to free cash flow | 57.25 | 82.37 | 73.01 | 96.93 | 154.51 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Free cash flow yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | -0.07 | 0 | 0.01 | 0 | 0 | |
Debt to assets | -0.06 | 0 | 0.01 | 0 | 0 | |
Net debt to EBITDA | -0.79 | -1.47 | -0.66 | -0.94 | -1.22 | |
Current ratio | 5.19 | 5.76 | 6.23 | 4.61 | 4.76 | |
Interest coverage | 0 | 0 | 0 | 40.78 | 0 | |
Income quality | 1.16 | 1.39 | 1.21 | 1.11 | 1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.12 | 0.14 | 0.12 | 0.14 | 0.14 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.06 | |
Capex to operating cash flow | -0.27 | -0.23 | -0.17 | -0.36 | -0.59 | |
Capex to revenue | -0.1 | -0.08 | -0.06 | -0.09 | -0.15 | |
Capex to depreciation | -2.1 | -1.24 | -1.14 | -1.46 | -2.52 | |
Stock based compensation to revenue | 0.07 | 0.09 | 0.08 | 0.08 | 0.08 | |
Graham number | 46.32 | 43.48 | 60.12 | 51.12 | 66.07 | |
ROIC | 0.16 | 0.07 | 0.14 | 0.09 | 0.12 | |
Return on tangible assets | 0.15 | 0.1 | 0.13 | 0.1 | 0.12 | |
Graham Net | 7.38 | 12.95 | 9.85 | 9.6 | 13.5 | |
Working capital | 6.06B | 6.71B | 8.39B | 6.72B | 6.23B | |
Tangible asset value | 7.98B | 9.42B | 11.61B | 10.76B | 12.41B | |
Net current asset value | 6.06B | 6.71B | 8.39B | 6.72B | 5.84B | |
Invested capital | -0.07 | 0 | 0.01 | 0 | 0 | |
Average receivables | 663.75M | 645.35M | 714.1M | 862.4M | 1.1B | |
Average payables | 592M | 582.45M | 101.4M | 134.1M | 167.85M | |
Average inventory | 502.25M | 598.5M | 594.3M | 740.15M | 1.06B | |
Days sales outstanding | 52.58 | 54.06 | 50.03 | 55.26 | 64.94 | |
Days payables outstanding | 288.98 | 19.89 | 25.26 | 26.48 | 28.76 | |
Days of inventory on hand | 158.85 | 146.64 | 122.34 | 160.9 | 186.05 | |
Receivables turnover | 6.94 | 6.75 | 7.3 | 6.6 | 5.62 | |
Payables turnover | 1.26 | 18.35 | 14.45 | 13.78 | 12.69 | |
Inventory turnover | 2.3 | 2.49 | 2.98 | 2.27 | 1.96 | |
ROE | 0.17 | 0.11 | 0.14 | 0.12 | 0.14 | |
Capex per share | -1.23 | -0.97 | -0.99 | -1.5 | -3.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.71 | 4.84 | 5 | 4.96 | 5.48 | |
Net income per share | 0.93 | 1.01 | 1.2 | 1.18 | 1.72 | |
Operating cash flow per share | 1.25 | 1.06 | 1.9 | 1.56 | 0.65 | |
Free cash flow per share | 0.86 | 0.51 | 1.39 | 0.83 | -0.59 | |
Cash per share | 11.74 | 8.34 | 16.53 | 18.41 | 14.83 | |
Book value per share | 31.65 | 32.25 | 34.08 | 35.65 | 37.79 | |
Tangible book value per share | 30.52 | 31.24 | 31.11 | 33.09 | 35.25 | |
Share holders equity per share | 31.65 | 32.25 | 34.08 | 35.65 | 37.79 | |
Interest debt per share | 0.13 | -0.08 | -0.57 | 0 | -0.16 | |
Market cap | 93.16B | 89.47B | 119.99B | 102.8B | 118.78B | |
Enterprise value | 91.68B | 89.09B | 116.55B | 99.2B | 116.12B | |
P/E ratio | 71.69 | 62.95 | 71.28 | 61.82 | 48.99 | |
Price to sales ratio | 56.29 | 52.74 | 68.33 | 58.95 | 61.6 | |
POCF ratio | 212.75 | 240.89 | 180.24 | 187.45 | 520.3 | |
PFCF ratio | 310.34 | 504.6 | 246.18 | 351.93 | -573.28 | |
P/B Ratio | 8.38 | 7.92 | 10.03 | 8.2 | 8.93 | |
PTB ratio | 8.38 | 7.92 | 10.03 | 8.2 | 8.93 | |
EV to sales | 55.39 | 52.53 | 66.38 | 56.89 | 60.22 | |
Enterprise value over EBITDA | 246.11 | 229.86 | 251.62 | 172.7 | 202.52 | |
EV to operating cash flow | 209.36 | 239.89 | 175.08 | 180.88 | 508.65 | |
EV to free cash flow | 305.39 | 502.51 | 239.13 | 339.6 | -560.44 | |
Earnings yield | 0 | 0 | 0 | 0 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | -0.02 | 0 | 0 | |
Debt to assets | 0 | 0 | -0.01 | 0 | 0 | |
Net debt to EBITDA | -3.99 | -0.96 | -7.42 | -6.27 | -4.64 | |
Current ratio | 4.61 | 4.8 | 4.65 | 5.31 | 4.76 | |
Interest coverage | 12 | -10.28 | 0 | 0 | 0 | |
Income quality | 1.3 | 1.03 | 1.56 | 1.31 | 0.37 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.15 | 0.14 | 0.14 | 0.14 | 0.13 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.07 | 0.06 | |
Capex to operating cash flow | -0.31 | -0.52 | -0.27 | -0.47 | -1.91 | |
Capex to revenue | -0.08 | -0.11 | -0.1 | -0.15 | -0.23 | |
Capex to depreciation | -1.3 | -2.09 | -1.83 | -2.36 | -3.53 | |
Stock based compensation to revenue | 0.08 | 0.08 | 0.08 | 0.09 | 0.08 | |
Graham number | 25.67 | 27.13 | 30.33 | 30.79 | 38.26 | |
ROIC | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | |
Return on tangible assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
Graham Net | 9.72 | 6.65 | 14.35 | 16.44 | 13.46 | |
Working capital | 6.72B | 6.69B | 7.1B | 7.23B | 6.23B | |
Tangible asset value | 10.76B | 10.95B | 11.61B | 11.64B | 12.41B | |
Net current asset value | 6.72B | 6.69B | 7.1B | 6.81B | 5.84B | |
Invested capital | 0 | 0 | -0.02 | 0 | 0 | |
Average receivables | 895.85M | 933.7M | 914.75M | 1B | 1.18B | |
Average payables | 155.6M | 81.95M | 108.3M | 197.95M | 192.45M | |
Average inventory | 865.15M | 919.9M | 975.9M | 1.08B | 1.18B | |
Days sales outstanding | 51.23 | 49.1 | 46.35 | 56.63 | 59.16 | |
Days payables outstanding | 24.32 | 2.61 | 30.78 | 30.63 | 26.09 | |
Days of inventory on hand | 147.74 | 146.08 | 154.91 | 179.14 | 168.77 | |
Receivables turnover | 1.76 | 1.83 | 1.94 | 1.59 | 1.52 | |
Payables turnover | 3.7 | 34.51 | 2.92 | 2.94 | 3.45 | |
Inventory turnover | 0.61 | 0.62 | 0.58 | 0.5 | 0.53 | |
ROE | 0.03 | 0.03 | 0.04 | 0.03 | 0.05 | |
Capex per share | -0.39 | -0.55 | -0.51 | -0.73 | -1.24 |
ISRG Frequently Asked Questions
What is Intuitive Surgical, Inc. stock symbol ?
Intuitive Surgical, Inc. is a US stock , located in Sunnyvale of Ca and trading under the symbol ISRG
Is Intuitive Surgical, Inc. buy or a sell ?
35 stock analysts have 35 predictions with a medium analyst target price of $309.14. The lowest prediction is $225 and the highest is $360
What is ISRG stock prediction ?
What is Intuitive Surgical, Inc. stock quote today ?
Intuitive Surgical, Inc. stock price is $399.09 today.
Is Intuitive Surgical, Inc. stock public?
Yes, Intuitive Surgical, Inc. is a publicly traded company.